{"data":[{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":1128647,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":1128647,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":1128647,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1045103,"percentOfClass":9.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":611834,"percentOfClass":5.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":611834,"percentOfClass":5.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":433269,"percentOfClass":3.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":433269,"percentOfClass":3.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":66808,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-002168","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":66808,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":1110002,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":1110002,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":1110002,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1026458,"percentOfClass":9.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":593189,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":593189,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":433269,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":433269,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":66808,"percentOfClass":0.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-26-001396","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":66808,"percentOfClass":0.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001140361-26-021307","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Blue Owl Capital Holdings LP","reportingCik":null,"personType":"PN","sharesOwned":959337,"percentOfClass":8.51,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000947871-26-000483","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G108","securityClass":"COMMON STOCK","eventDate":"2026-04-14","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":1495045,"percentOfClass":13.1,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000947871-26-000483","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G108","securityClass":"COMMON STOCK","eventDate":"2026-04-14","reportingPerson":"ORBIMED CAPITAL GP VI LLC","reportingCik":"0001682115","personType":"OO","sharesOwned":1089665,"percentOfClass":9.6,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000947871-26-000483","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G108","securityClass":"COMMON STOCK","eventDate":"2026-04-14","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":"0001808744","personType":"OO","sharesOwned":405380,"percentOfClass":3.6,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000947871-26-000483","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G108","securityClass":"COMMON STOCK","eventDate":"2026-04-14","reportingPerson":"ORBIMED CAPITAL LLC","reportingCik":"0001157524","personType":"IA","sharesOwned":135516,"percentOfClass":1.2,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001493152-26-018316","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-14","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":1176472,"percentOfClass":9.9,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001493152-26-018316","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-14","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1176472,"percentOfClass":9.9,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001493152-26-018316","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-14","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":1176472,"percentOfClass":9.9,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001193125-26-166691","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Claudio Nessi","reportingCik":null,"personType":"IN","sharesOwned":935843,"percentOfClass":8.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001193125-26-166691","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Otello Stampacchia","reportingCik":null,"personType":"IN","sharesOwned":936222,"percentOfClass":8.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001193125-26-166691","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Omega Fund VI, L.P.","reportingCik":"0001757917","personType":"PN","sharesOwned":935843,"percentOfClass":8.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001193125-26-166691","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Omega Fund VI GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":935843,"percentOfClass":8.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001193125-26-166691","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":"45175G207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Omega Fund VI GP Manager, Ltd.","reportingCik":null,"personType":"OO","sharesOwned":935843,"percentOfClass":8.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001172661-26-000716","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001172661-26-000716","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001172661-26-000716","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835579","issuerName":"IMAGENEBIO, INC.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001140361-26-005001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Blue Owl Capital Holdings LP","reportingCik":null,"personType":"PN","sharesOwned":823785,"percentOfClass":7.37,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0002073679-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-29","reportingPerson":"Funicular Funds, LP","reportingCik":null,"personType":"PN","sharesOwned":643933,"percentOfClass":5.8,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0002073679-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-29","reportingPerson":"Cable Car Capital, LP","reportingCik":null,"personType":"PN,IA","sharesOwned":643933,"percentOfClass":5.8,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0002073679-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-29","reportingPerson":"Ma-Weaver Jacob","reportingCik":null,"personType":"IN","sharesOwned":643933,"percentOfClass":5.8,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":802102,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":802102,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":802102,"percentOfClass":7.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":741361,"percentOfClass":6.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0001140361-25-042297","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Blue Owl Capital Holdings LP","reportingCik":null,"personType":"PN","sharesOwned":540924,"percentOfClass":4.84,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":415765,"percentOfClass":3.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":415765,"percentOfClass":3.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":325596,"percentOfClass":2.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":325596,"percentOfClass":2.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":44578,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"},{"accessionNo":"0000921895-25-003102","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835579","issuerName":"ImageneBio, Inc.","ticker":"IMA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":44578,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ima"}],"updatedAt":"2026-11-04T00:26:22.311Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ima","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}